Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Mangeney

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|March 22, 2006
A recombinant endogenous retrovirus amplified in a mouse neuroblastoma is involved in tumor growth in vivoJulien Pothlichet, Thierry Heidmann, Marianne Mangeney
The Journal of General Virology|June 20, 2001
The envelope of Mason-Pfizer monkey virus has immunosuppressive propertiesSandra Blaise, Marianne Mangeney, Thierry Heidmann
International Journal of Cancer|May 19, 2006
Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivoJulien Pothlichet, Marianne Mangeney, Thierry Heidmann
The Journal of General Virology|September 20, 2001
The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive propertiesMarianne Mangeney, Nathalie de Parseval, Gilles Thomas, et al.
Cancer Research|April 5, 2005
Endogenous retrovirus expression is required for murine melanoma tumor growth in vivoMarianne Mangeney, Julien Pothlichet, Martial Renard, et al.
Journal of Virology|November 8, 2013
A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccineGéraldine Schlecht-Louf, Marianne Mangeney, Hanane El-Garch, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2010
Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretrovirusesGéraldine Schlecht-Louf, Martial Renard, Marianne Mangeney, et al.
Oncotarget|August 25, 2016
FAM65B controls the proliferation of transformed and primary T cellsJeanne Froehlich, Margaux Versapuech, Laura Megrelis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteinsMarianne Mangeney, Martial Renard, Géraldine Schlecht-Louf, et al.
Cancer Immunology Research|August 30, 2023
FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid TumorsMaude Marchais, Luca Simula, Mélanie Phayanouvong, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|March 22, 2006
A recombinant endogenous retrovirus amplified in a mouse neuroblastoma is involved in tumor growth in vivoJulien Pothlichet, Thierry Heidmann, Marianne Mangeney
The Journal of General Virology|June 20, 2001
The envelope of Mason-Pfizer monkey virus has immunosuppressive propertiesSandra Blaise, Marianne Mangeney, Thierry Heidmann
International Journal of Cancer|May 19, 2006
Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivoJulien Pothlichet, Marianne Mangeney, Thierry Heidmann
The Journal of General Virology|September 20, 2001
The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive propertiesMarianne Mangeney, Nathalie de Parseval, Gilles Thomas, et al.
Cancer Research|April 5, 2005
Endogenous retrovirus expression is required for murine melanoma tumor growth in vivoMarianne Mangeney, Julien Pothlichet, Martial Renard, et al.
Journal of Virology|November 8, 2013
A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccineGéraldine Schlecht-Louf, Marianne Mangeney, Hanane El-Garch, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2010
Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretrovirusesGéraldine Schlecht-Louf, Martial Renard, Marianne Mangeney, et al.
Oncotarget|August 25, 2016
FAM65B controls the proliferation of transformed and primary T cellsJeanne Froehlich, Margaux Versapuech, Laura Megrelis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteinsMarianne Mangeney, Martial Renard, Géraldine Schlecht-Louf, et al.
Cancer Immunology Research|August 30, 2023
FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid TumorsMaude Marchais, Luca Simula, Mélanie Phayanouvong, et al.
Pageof 2